Angiogenic factors in laryngeal carcinomas: Do they have prognostic relevance?

Acta Oto-Laryngologica

Volumn 119, Issue 2, 1999, Pages 289-292

  Burian, M ^a   Quint, Ch ^a   Neuchrist, C ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Angiogenesis; Cancer; Larynx; Prognosis

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; MATRIX METALLOPROTEINASE; VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER SURVIVAL; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LARYNX CARCINOMA; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN LOCALIZATION; STROMA CELL; SURVIVAL RATE; TUMOR CELL; TUMOR GROWTH;

CARCINOMA, SQUAMOUS CELL; ENDOTHELIAL GROWTH FACTORS; FEMALE; FIBROBLAST GROWTH FACTOR 2; HUMANS; LARYNGEAL NEOPLASMS; LARYNX; LYMPHOKINES; MALE; METALLOENDOPEPTIDASES; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0032925102     PISSN: 00016489     EISSN: None     Source Type: Journal    
DOI: 10.1080/00016489950181846     Document Type: Article

References (22)

1. Kuiper RA, Schellens JH, Blijham GH, Beijnen JH, Voest EE. Clinical research on antiangiogenic therapy. Pharmacol Res 1998; 37: 1-16.
2. Twardowski P, Gradishar WJ. Clinical trials of antiangiogenic agents. Curr Opin Oncol 1997; 9: 584-9.
3. Weidner N. Intratumor microvessel density as a prognostic factor in cancer. Am J Pathol 1995; 147: 9-19.
4. Weidner N, Folkman J, Pozza F, et al. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 1992; 84: 1875-87.
5. Inoue K, Ozeki Y, Suganuma T, Sugiura Y, Tanaka S. Vascular endothelial growth factor expression in primary esophageal squamous cell carcinoma. Association with angiogenesis and tumor progression. Cancer 1997; 79: 206-13.
6. Kusukawa J, Sasaguri Y, Morimatsu M, Kameyama T. Expression of matrix metalloproteinase-3 in stage I and II squamous cell carcinoma of the oral cavity. J Oral Maxillofac Surg 1995; 53: 530-4.
7. Nelson NJ. Inhibitors of angiogenesis enter phase III testing. J Natl Cancer Inst 1998; 90: 960-3.
8. Weidner N. Tumoural vascularity as a prognostic factor in cancer patients: the evidence continues to grow. J Pathol 1998; 184: 119-22.
9. Narita M, Nakao K, Ogino N, Nakahara M, Onishi A, Tsujimoto M. Independent prognostic factors in breast cancer patients. Am J Surg 1998; 175: 73-5.
10. Weidner N, Folkman J, Pozza F, et al. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 1992; 84: 1875-87.
11. Murray JD, Carlson GW, McLaughlin K, et al. Tumor angiogenesis as a prognostic factor in laryngeal cancer. Am J Surg 1997; 174: 523-6.
12. Beatrice F, Giusti U, Bisciari T, et al. Microvessel count is predictive of patients' survival in laryngeal squamous-cell carcinoma. Int J Cancer 1996; 69: 426-7.
13. Janot F, el-Naggar AK, Morrison RS, Liu TJ, Taylor DL, Clayman GL. Expression of basic fibroblast growth factor in squamous cell carcinoma of the head and neck is associated with degree of histologic differentiation. Int J Cancer 1995; 64: 117-23.
14. Dellacono FR, Spiro J, Eisma R, Kreutzer D. Expression of basic fibroblast growth factor and its receptors by head and neck squamous carcinoma tumor and vascular endothelial cells. Am J Surg 1997; 174: 540-4.
15. Hughes CJ, Reed JA, Cabal R, Huvos AG, Albino AP, Schantz SP. Increased expression of basic fibroblast growth factor in squamous carcinogenesis of the head and neck is less prevalent following smoking cessation. Am J Surg 1994; 168: 381-5.
16. Miyajima Y, Nakano R, Morimatsu M. Analysis of expression of matrix metalloproteinases-2 and -9 in hypopharyngeal squamous cell carcinoma by in situ hybridization. Ann Otol Rhinol Laryngol 1995; 104: 678-84.
17. Kawamata H, Nakashiro K, Uchida D, Harada K, Yoshida H, Sato M. Possible contribution of active MMP2 to lymph-node metastasis and secreted cathepsin L to bone invasion of newly established human oral-squamous-cancer cell lines. Int J Cancer 1997; 70: 120-7.
18. Kusukawa J, Sasaguri Y, Shima I, Kameyama T, Morimatsu M. Expression of matrix metalloproteinase-2 related to lymph node metastasis of oral squamous cell carcinoma. A clinicopathologic study. Am J Clin Pathol 1993; 99: 18-23.
19. Rasmussen HS, McCann PP. Matrix metalloproteinase inhibition as a novel anticancer strategy: a review with special focus on batimastat and marimastat. Pharmacol Ther 1997; 75: 69-75.
20. Wiernik G, Millard PR, Haybittle JL. The predictive value of histological classification into degrees of differentiation of squamous cell carcinoma of the larynx and hypopharynx compared with the survival of patients. Histopathology 1991; 19: 411-7.
21. Salven P, Heikkila P, Anttonen A, Kajanti M, Joensuu H. Vascular endothelial growth factor in squamous cell head and neck carcinoma: expression and prognostic significance. Mod Pathol 1997; 10: 1128-33.
22. Eisma RJ, Spiro JD, Kreutzer DL. Vascular endothelial growth factor expression in head and neck squamous cell carcinoma. Am J Surg 1997; 174: 513-7.